Ovarian germ cell tumor surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}{{AE}} {{MD}} | {{CMG}}{{AE}} {{MD}} | ||
'''Stage I ovarian germ cell tumors''' | |||
* Standard treatment options: | * Standard treatment options: | ||
* Dysgerminomas | * Dysgerminomas | ||
Line 13: | Line 13: | ||
* Unilateral salpingo-oophorectomy followed by observation | * Unilateral salpingo-oophorectomy followed by observation | ||
Stage II ovarian germ cell tumors | '''Stage II ovarian germ cell tumors''' | ||
* Standard treatment options: | * Standard treatment options: | ||
* Dysgerminomas | * Dysgerminomas | ||
* Total abdominal hysterectomy and bilateral salpingo-oophorectomy with adjuvant radiation therapy or chemotherapy | * Total abdominal hysterectomy and bilateral salpingo-oophorectomy with adjuvant radiation therapy or chemotherapy | ||
* Unilateral salpingo-oophorectomy with adjuvant chemotherapy | * Unilateral salpingo-oophorectomy with adjuvant chemotherapy | ||
* Other germ cell tumors | * Other germ cell tumors | ||
* Unilateral salpingo-oophorectomy with adjuvant chemotherapy | * Unilateral salpingo-oophorectomy with adjuvant chemotherapy | ||
* Second-look laparotomy | * Second-look laparotomy | ||
Stage III ovarian germ cell | '''Stage III ovarian germ cell tumors''' | ||
* Standard treatment options: | * Standard treatment options: | ||
* Dysgerminomas | * Dysgerminomas | ||
Line 31: | Line 31: | ||
* Unilateral salpingo-oophorectomy with adjuvant chemotherapy, with or without neoadjuvant chemotherapy | * Unilateral salpingo-oophorectomy with adjuvant chemotherapy, with or without neoadjuvant chemotherapy | ||
* Second-look laparotomy | * Second-look laparotomy | ||
'''Stage IV ovarian germ cell tumors''' | |||
* Standard treatment options: | * Standard treatment options: | ||
* Dysgerminomas | * Dysgerminomas |
Revision as of 17:27, 5 November 2015
Ovarian germ cell tumor Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ovarian germ cell tumor surgery On the Web |
American Roentgen Ray Society Images of Ovarian germ cell tumor surgery |
Risk calculators and risk factors for Ovarian germ cell tumor surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Stage I ovarian germ cell tumors
- Standard treatment options:
- Dysgerminomas
- Unilateral salpingo-oophorectomy with or without lymphangiography or computed tomography (CT)
- Unilateral salpingo-oophorectomy followed by observation
- Unilateral salpingo-oophorectomy with adjuvant radiation therapy or chemotherapy
- Other germ cell tumors
- Unilateral salpingo-oophorectomy with adjuvant chemotherapy
- Unilateral salpingo-oophorectomy followed by observation
Stage II ovarian germ cell tumors
- Standard treatment options:
- Dysgerminomas
- Total abdominal hysterectomy and bilateral salpingo-oophorectomy with adjuvant radiation therapy or chemotherapy
- Unilateral salpingo-oophorectomy with adjuvant chemotherapy
- Other germ cell tumors
- Unilateral salpingo-oophorectomy with adjuvant chemotherapy
- Second-look laparotomy
Stage III ovarian germ cell tumors
- Standard treatment options:
- Dysgerminomas
- Total abdominal hysterectomy and bilateral salpingo-oophorectomy
- Unilateral salpingo-oophorectomy with adjuvant chemotherapy
- Other germ cell tumors
- Total abdominal hysterectomy and bilateral salpingo-oophorectomy with adjuvant chemotherapy, with or without neoadjuvant chemotherapy
- Unilateral salpingo-oophorectomy with adjuvant chemotherapy, with or without neoadjuvant chemotherapy
- Second-look laparotomy
Stage IV ovarian germ cell tumors
- Standard treatment options:
- Dysgerminomas
- Total abdominal hysterectomy and bilateral salpingo-oophorectomy with adjuvant chemotherapy
- Unilateral salpingo-oophorectomy with adjuvant chemotherapy
- Other germ cell tumors
- Total abdominal hysterectomy and bilateral salpingo-oophorectomy with adjuvant chemotherapy with or without neoadjuvant chemotherapy
- Unilateral salpingo-oophorectomy with adjuvant chemotherapy with or without neoadjuvant chemotherapy